Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; miranol 2mca 0.2%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01%/0.2%/0.004% - active: disodium edetate dihydrate 0.01%{relative} miranol 2mca 0.2%{relative} thiomersal 0.004%{relative}

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; sodium polymetaphosphate 0.2%;  ; thiomersal 0.001% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     sodium polymetaphosphate 0.2%   thiomersal 0.001%

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.05% - contact lens solution - 0.5 mg/ml - active: disodium edetate dihydrate 0.05%

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.25%; sodium edetate 0.25%; sorbic acid 0.1% - contact lens solution - active: disodium edetate dihydrate 0.25% sodium edetate 0.25% sorbic acid 0.1% excipient: poloxamer 407 potassium chloride purified water sodium chloride

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.2%{relative}; hyetellose 0.792%{relative}; sodium chloride 0.422%{relative} - contact lens solution - active: disodium edetate dihydrate 0.2%{relative} hyetellose 0.792%{relative} sodium chloride 0.422%{relative} excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polyvinyl alcohol purified water thiomersal tyloxapol

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - disodium edetate dihydrate 0.1%{relative}; polysorbate 80 0.05%{relative}; polyvinyl alcohol 0.75%{relative}; sodium chloride 0.458%{relative} - contact lens solution - active: disodium edetate dihydrate 0.1%{relative} polysorbate 80 0.05%{relative} polyvinyl alcohol 0.75%{relative} sodium chloride 0.458%{relative} excipient: dibasic sodium phosphate hyetellose monobasic sodium phosphate dihydrate purified water thiomersal

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.025%; potassium sorbate 0.13% (+ 10% overage = 0.147%w/v); sodium chloride 0.43% - contact lens solution - active: disodium edetate dihydrate 0.025% potassium sorbate 0.13% (+ 10% overage = 0.147%w/v) sodium chloride 0.43% excipient: borax boric acid hydrochloric acid purified water sodium hydroxide

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

bausch health us, llc - edetate calcium disodium (unii: 25ih6r4sgf) (edetic acid - unii:9g34hu7rv0) - edetate calcium disodium 200 mg in 1 ml - edetate calcium disodium is indicated for the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. chelation therapy should not replace effective measures to eliminate or reduce further exposure to lead. edetate calcium disodium should not be given during periods of anuria, nor to patients with active renal disease or hepatitis.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate -